Faith L. Charles insider trades

Open-market stock purchases and sales by Faith L. Charles, Director at CNS Pharmaceuticals, Inc, from SEC Form 4 filings since May 25, 2021.

Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +19%.

Recent trades

DateStockTradeValue
May 18, 2026CNSP CNS Pharmaceuticals, IncBought$34K
Jan 26, 2026ABEO Abeona Therapeutics IncBought (not open market)—
Nov 17, 2025CNSP CNS Pharmaceuticals, IncBought (not open market)—

Companies traded

  • CNSP CNS Pharmaceuticals, Inc: 1 buy, last May 18, 2026
  • ABEO Abeona Therapeutics Inc: 1 buy, 2 sales, last Jan 26, 2026
  • CDT Conduit Pharmaceuticals Inc: other filings, last Apr 16, 2025
  • ATXI Avenue Therapeutics, Inc: other filings, last Sep 23, 2024

Get free alerts when Faith L. Charles files a new trade →